Clarissa Desjardins

Active Investor

Co-Founder & Chief Executive Officer

Montréal, Canada

Clarissa Desjardins, Co-Founder & Chief Executive Officer is an active investor based in Montréal, Canada. This profile covers what Clarissa Desjardins backs, at which stage, and how founders can reach out in 2026.

Dr. Clarissa Desjardins is a Co-Founder & serves as Chief Executive Officer at Congruence Therapeutics. Dr. Desjardins serves as Board Member & Chair of the Science & Technology Committee at Insmed. Before Caprion, he co-founded Advanced Bioconcept Inc. in 1992. She served there until 1998, most recently as Vice President, Business Development. Dr. Desjardins currently serves on the Board of Directors of BELLUS Health Inc. (Nasdaq: BLU; TSX: BLU) and Xenon Therapeutics (Nasdaq: XENE). Dr. Desjardins received a Bachelor of Science degree in Anatomical Sciences and History and Philosophy of Science and a Ph.D. in Neurology and Neurosurgery, each from McGill University in Montreal, Quebec, Canada. Dr. Desjardins was a Medical Research Council postdoctoral fellow at Douglas Hospital Research Centre at McGill University. Dr. Desjardins is chair of the Science & Technology Committee.

Investor type: Angel
Stages: Seed
Invests in: Biotech & Pharma
Location: Montréal, Canada
Typical check: $250K
Past investments: 1

Notable investments

Congruence Therapeutics

How to reach Clarissa Desjardins

Angels and operators like Clarissa Desjardins reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Clarissa Desjardins invest in?

Clarissa Desjardins invests in Biotech & Pharma, typically at Seed. Match your sector and stage, then reach out with a personalized pitch.

How do I contact Clarissa Desjardins?

Unlock Clarissa Desjardins's verified email on Round Funded and send a personalized pitch. We surface only deliverable contacts so your outreach lands.